Here's the same subject matter in the article with less technical terms.
Awakening Dormant Neurons Could Provide Disease-modifying Parkinson’s Treatment, Early Study Suggests
parkinsonsnewstoday.com/202...
Quote:Although the results from several clinical trials have cast doubt on the therapeutic efficacy of traditional MAO-B inhibitors, researchers say they have recently developed a new inhibitor, KDS2010. KDS2010 effectively inhibits astrocytic GABA production with minimal side effects in Alzheimer’s animal models and also could be effective for alleviating Parkinson’s motor symptoms, the investigators said.